review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JANXDIS.2011.01.002 |
P698 | PubMed publication ID | 21315551 |
P50 | author | Francisco López-Muñoz | Q30002142 |
Cecilio Alamo | Q115598132 | ||
P2093 | author name string | Pilar García-García | |
P433 | issue | 4 | |
P304 | page(s) | 554-562 | |
P577 | publication date | 2011-01-22 | |
P1433 | published in | Journal of Anxiety Disorders | Q15758849 |
P1476 | title | The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: half a century of anxiolytic drugs | |
P478 | volume | 25 |
Q61886048 | A History of the Pharmacological Treatment of Bipolar Disorder |
Q47706097 | Anxiolytic effects of orcinol glucoside and orcinol monohydrate in mice |
Q47446098 | Benzodiazepines: Sedation and Agitation |
Q34596067 | Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment |
Q52309749 | Commentary on Smith et al. (2016): Gabapentin-looks like a drug that can be misused…, probably is a drug that can be misused. |
Q26773288 | Concerns about quetiapine |
Q90261306 | Effect of reimbursement restriction policy on the use of benzodiazepines in the Netherlands: an interrupted time series analysis |
Q48137427 | Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults |
Q45908446 | Illegal use of benzodiazepines and/or zolpidem proved by hair analysis. |
Q40109757 | Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis |
Q89928458 | Psychotropic Drug-Associated Pneumonia in Older Adults |
Q34681144 | Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior? |
Q38831602 | Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases |
Q34378869 | The neurobiology of alcohol consumption and alcoholism: an integrative history |
Q45906577 | The preclinical discovery and development of ezogabine for the treatment of epilepsy. |